Stocks Comparison
Agilent Technologies vs 10x Genomics: revenue, profit, margins and growth compared
Agilent Technologies brought in $6.9B of revenue in fiscal 2025, 10x Genomics $642.8M in fiscal 2025. Revenue changed by +6.7% at Agilent Technologies and +5.2% at 10x Genomics on the year before, so Agilent Technologies grew faster. Agilent Technologies kept 18.8% of its revenue as net profit, 10x Genomics -6.8%. Free cash flow was $1.2B at Agilent Technologies and $130.1M at 10x Genomics.
Side by side, latest fiscal year
| A | TXG | |
|---|---|---|
| Fiscal year ended | FY2025 (October 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $6.9B | $642.8M |
| Revenue growth | +6.7% | +5.2% |
| Net income | $1.3B | -$43.5M |
| Net margin | 18.8% | -6.8% |
| Free cash flow | $1.2B | $130.1M |
| Free cash flow margin | 16.6% | 20.2% |
| Earnings per share (diluted) | $4.57 | -$0.35 |
| Cash | $1.8B | $474M |
| Debt | $3.1B | n/a |
| Price to earnings | 37.8 | n/a |
| Market value | $48.8B | $11.2B |
| Dividend yield | 0.57% | n/a |
| Rank by revenue in sector | #97 of 451 · Industrials | #299 of 451 · Industrials |
Over the years
Questions about Agilent Technologies and 10x Genomics
Which is bigger by revenue, Agilent Technologies or 10x Genomics?
Agilent Technologies is bigger by revenue: $6.9B in fiscal 2025, against $642.8M for 10x Genomics in fiscal 2025.
Which keeps more of its revenue as profit, Agilent Technologies or 10x Genomics?
Agilent Technologies had a net margin of 18.8% in fiscal 2025; 10x Genomics had -6.8% in fiscal 2025.
Which grew revenue faster, Agilent Technologies or 10x Genomics?
In their latest fiscal years revenue changed by +6.7% at Agilent Technologies and +5.2% at 10x Genomics.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.